We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ELTP market cap is 134.86M. The company's latest EPS is USD 0.0035 and P/E is 37.14.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.57M | 18M | 25.38M | 32.26M | 34.16M |
| Operating Income | -9.16M | -2.29M | 2.1M | 5.07M | 3.68M |
| Net Income | -9.28M | -2.24M | 5.09M | 8.9M | 3.56M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.4M | 24.96M | 26.19M | 35.15M | 40.9M |
| Total Liabilities | 13.01M | 14.3M | 10.04M | 9.93M | 11.94M |
| Total Equity | -2.51M | 10.66M | 16.15M | 25.22M | 28.96M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.79M | -1.79M | 3.19M | 6.51M | 3.34M |
| Investing | 331k | -35k | -263k | -499k | -5.74M |
| Financing | 1.57M | 690k | -870k | -667k | 1.7M |
| Market Cap | 134.86M |
| Price to Earnings Ratio | 37.14 |
| Price to Sales Ratio | 3.87 |
| Price to Cash Ratio | 16.88 |
| Price to Book Ratio | 4.57 |
| Dividend Yield | - |
| Shares Outstanding | 1.02B |
| Average Volume (1 week) | 696.42k |
| Average Volume (1 Month) | 550.74k |
| 52 Week Change | 321.97% |
| 52 Week High | 0.2119 |
| 52 Week Low | 0.0281 |
| Spread (Intraday) | 0.02 (11.86%) |
| Company Name | Elite Pharmaceuticals Inc (QB) |
| Address |
321 w. winnie lane carson city, nevada 89703 |
| Website | https://www.elitepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
